CVRx/$CVRX
1D1W1MYTD1Y5YMAX
Capital at risk
About CVRx
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
- Ticker
- $CVRX
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 223
- Headquarters
- Minneapolis, United States
- Website
- www.barostim.com
CVRx Metrics
BasicAdvanced
$81M
-
-$1.97
0.82
-
Price and volume
Market cap
$81M
Beta
0.82
52-week high
$11.30
52-week low
$2.20
Average daily volume
1.4M
Financial strength
Current ratio
8.045
Quick ratio
6.651
Long term debt to equity
2.958
Total debt to equity
2.976
Interest coverage (TTM)
-8.07%
Profitability
EBITDA (TTM)
-47.843
Gross margin (TTM)
86.92%
Net profit margin (TTM)
-84.93%
Operating margin (TTM)
-79.49%
Effective tax rate (TTM)
0.01%
Revenue per employee (TTM)
$270,000
Management effectiveness
Return on assets (TTM)
-28.70%
Return on equity (TTM)
-133.44%
Valuation
Price to revenue (TTM)
1.307
Price to book
4.06
Price to tangible book (TTM)
4.06
Price to free cash flow (TTM)
-1.949
Free cash flow yield (TTM)
-51.32%
Free cash flow per share (TTM)
-1.56
Growth
Revenue change (TTM)
11.96%
Earnings per share change (TTM)
-6.01%
3-year revenue growth (CAGR)
25.65%
3-year earnings per share growth (CAGR)
-2.06%
What the Analysts think about CVRx
Analyst ratings (Buy, Hold, Sell) for CVRx stock.
Analyst projections of the future price of CVRx stock.
CVRx Financial Performance
Revenues and expenses
CVRx Earnings Performance
Company profitability
Upcoming events
No upcoming events
CVRx News
AllArticlesVideos
CVRx, Inc. Investors Who Suffered Losses Should Contact Block & Leviton LLP
Newsfile Corp4 weeks ago
CVRx, Inc. Investigated For Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm
Newsfile Corp1 month ago
CVRX ALERT: Securities Fraud Investigation by Block & Leviton Could Allow CVRx, Inc. Investors to Recover Losses
Newsfile Corp1 month ago
Funds containing CVRx
Fund name | Fund size | $CVRX weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.00% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.